Autolus Therapeutics (AUTL)
(Delayed Data from NSDQ)
$4.10 USD
+0.25 (6.49%)
Updated Sep 4, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 33% (84 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.38 | 1.37 | 9.99 |
Current Quarter Estimate | -0.21 | 2.92 | 61.00 |
Year Ago Quarter Estimate | -0.26 | -4.86 | 54.84 |
Next Quarter Estimate | -0.18 | 3.90 | 63.00 |
Next Year Estimate | -0.70 | 25.15 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 30.00 | 17.70 | 15.67 |
Next Year | 16.67 | 9.60 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | NA | 21.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -6.80 |
Price/Book (MRQ) | 2.07 | 2.05 |
Price/Cash Flow (MRFY) | NA | 17.40 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -147.72% |
Return on Equity (TTM) | -66.76% | -60.91% |
Debt to Equity (MRQ) | 0.09 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.